Study 3 | National Headache Foundation

National Headache Foundation Accepting Grant Applications for Cluster Headache Research

May 26, 2016

The National Headache Foundation has been supporting clinical and basic science research in headache and its causes for over 25 years. These grants have served as springboards to obtaining over $7 million in federal funding of headache-related research. Newer resources…

Rush University Medical Center Seeking Participants for Sleep-Chronic Migraine Study

February 13, 2016

Rush University Medical Center is no longer seeking participants for this study. Researchers at Rush University Medical Center in Chicago are currently seeking participants for a study examining the sleep patterns of women who experience chronic migraine. The study intends to test…

Cluster Headache Study Seeks Participants

December 8, 2015

Cluster headache is one of the most severe pains known to humans. This condition causes intense stabbing or burning pain in or around the eye. If you suffer from chronic cluster headache, you may be eligible to participate in a…

NHF-Sponsored Study Says Migraine Disease May Worsen for Patients with Asthma

December 7, 2015

Individuals with asthma who also experience episodic or occasional migraine may be more likely to develop chronic migraine, according to a National Headache Foundation-sponsored study, recently published online in the journal Headache. “If you have asthma along with episodic or…

Curelator: A New Tool for Identifying Migraine Headache Protectors and Triggers

November 24, 2015

By Alec Mian, PhD, CEO, Curelator Inc. and Stephen Donoghue, PhD, VP Clinical Development, Curelator Inc. Curelator Headache Population Map Displays Trigger & Protector Profiles for 150 Migraineurs Curelator Headache is a transformational digital tool that allows individuals to track and discover…

Curelator and National Headache Foundation Study Challenges Conventional Wisdom About Migraine Triggers

November 23, 2015

Cambridge, MA and Chicago, IL, Dec 1, 2015 – Chocolate, caffeine and red wine, frequently cited as “likely migraine triggers” may be just as responsible for protecting against migraine attacks as contributing to them, according to the results of an…

American Migraine Study II: Americans' Behavior Toward Migraine Not In Line with Knowledge

February 6, 2008

Americans know what it is. And a new public opinion poll shows they know what to do about it. Yet, most Americans’ behavior toward it is not in line with their knowledge — and they are suffering needlessly as a…

American Migraine Study II

November 20, 2007

Fact Sheet A study conducted for the National Headache Foundation (NHF) and underwritten by a grant from Glaxo Wellcome Inc. (now GlaxoSmithKline) measures the prevalence of migraine headache in America and quantifies the impact this disabling disease has on the…

AMPP Fact Sheet

August 11, 2007

About the AMPP Study The American Migraine Prevalence and Prevention (AMPP) Study is the largest study of migraine sufferers ever conducted, analyzing symptoms and treatment patterns in a representative sample of 162,576 Americans age 12 and older. The study found…

Facts About Migraine

August 12, 2005

Facts About the Impact of Migraine Almost 40 million Americans have migraine. Migraine attacks typically start during adolescence or the 20s. 52% of people living with migraine disease are undiagnosed by a healthcare provider. Migraine is misdiagnosed as tension (a…

Largest Study Ever of Migraine Sufferers Reveals Preventive Therapies Remain Untapped

June 24, 2005

PHILADELPHIA, June 24, 2005 – Findings from the largest study of headache sufferers ever conducted sponsored by the National Headache Foundation were presented today. Results from the American Migraine Prevalence and Prevention (AMPP) Study indicate that 40 percent of migraine sufferers…

A 10-Year Report Card Shows Migraine Remains Underdiagnosed and Undertreated

February 22, 2000

CHICAGO, February 22, 2000 – A new study – the American Migraine Study II – reports that patient treatment patterns have not kept pace with major scientific breakthroughs in the field. Unfortunately, despite a better understanding of the disease and medications designed…

‹ Previous